Đang chuẩn bị liên kết để tải về tài liệu:
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Triple-negative breast cancer (TNBC) represents an aggressive subtype with limited therapeutic options. Experimental preclinical models that recapitulate their tumors of origin can accelerate target identification, thereby potentially improving therapeutic efficacy. | Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

TÀI LIỆU LIÊN QUAN

Detection of pre-extensively drug resistance (PRE-XDR TB) and extensively drug resistance (XDR-TB) among pulmonary multidrug resistant tuberculosis (MDR-TB) patient by line probe assay

Study on prevalance of drug resistance and genetic mutation for drug resistance HIV on HIV/AIDS patients with first line antiretroviral treatment failure at Dongda hospital Ha Noi

Multi-drug resistance and extended-spectrum β-lactamase production in uropathogens from hospitalized patients in Gurugram, India

Ebook Bacterial Resistance to Antimicrobials

Prospects of Indole derivatives as methyl transfer inhibitors: Antimicrobial resistance managers

Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model

Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients

Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells

Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway

Systematic functional identification of cancer multi-drug resistance genes